25T7-NBOMe

25T7-NBOMe
Clinical data
Other names	2C-T-7-NBOMe; NBOMe-2C-T-7; N-(2-Methoxybenzyl)-4-propylthio-2,5-dimethoxyphenethylamine
Drug class	Serotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code	None;
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics);
Identifiers
	IUPAC name 2-(2,5-dimethoxy-4-propylsulfanylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine;
CAS Number	1539266-55-1 ;
PubChem CID	125181253;
CompTox Dashboard (EPA)	DTXSID701342517 ;
Chemical and physical data
Formula	C21H29NO3S
Molar mass	375.53 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCCSC1=C(C=C(C(=C1)OC)CCNCC2=CC=CC=C2OC)OC;
	InChI InChI=1S/C21H29NO3S/c1-5-12-26-21-14-19(24-3)16(13-20(21)25-4)10-11-22-15-17-8-6-7-9-18(17)23-2/h6-9,13-14,22H,5,10-12,15H2,1-4H3; Key:CPVMNHOHOSNFOP-UHFFFAOYSA-N;

25T7-NBOMe (also known as 2C-T-7-NBOMe or NBOMe-2C-T-7) is a substituted phenethylamine derivative from the 25-NB family. It acts as an agonist at the 5-HT_2A and 5-HT_2C serotonin receptors, has psychedelic effects and has been sold as a designer drug. The active dose range of 25T7-NBOMe does not appear to have been described. Its affinities and activities at a variety of other receptors and transporters have also been described. 25T7-NBOMe was first described in the scientific literature by 2012.